Picture of Seres Therapeutics logo

MCRB — Seres Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Seres Therapeutics Files Prospectus Related To Resale Of Up To 14.3 Million Shares Of Common Stock

Oct 1 (Reuters) - Seres Therapeutics Inc  MCRB.O :
    * SERES THERAPEUTICS FILES PROSPECTUS RELATED TO RESALE,FROM
TIME
TO TIME, OF UP TO 14.3 MILLION SHARES OF COMMON STOCK BY 
SELLING STOCKHOLDER- SEC FILING

Source text for Eikon:  ID:n0001193125-24-230253 
Further company coverage:  MCRB.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Seres Therapeutics

See all news